You may find more results for this query on our sister sites: GenomeWeb and Precision Oncology News.
NEW YORK – The US Food and Drug Administration issued finalized guidance on Tuesday for in vitro diagnostic test manufacturers designing studies for devices for CLIA waiver submissions and dual submissions for 510(k) clearance and CLIA waivers.
...and receive Daily News bulletins.
Already have a 360Dx or GenomeWeb account?Login Now.
Don't have a 360Dx or GenomeWeb account?Register for Free.